Terumo Co. (OTCMKTS:TRUMY) Sees Large Increase in Short Interest

Terumo Co. (OTCMKTS:TRUMY) was the recipient of a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 51,900 shares, an increase of 111.8% from the July 31st total of 24,500 shares. Based on an average daily trading volume, of 184,300 shares, the short-interest ratio is currently 0.3 days.

Terumo Price Performance

Shares of TRUMY stock traded down $0.48 during trading on Friday, hitting $18.57. The company had a trading volume of 44,295 shares, compared to its average volume of 58,870. The company has a quick ratio of 1.13, a current ratio of 1.90 and a debt-to-equity ratio of 0.06. Terumo has a 52 week low of $12.56 and a 52 week high of $20.60. The stock has a market capitalization of $27.68 billion, a price-to-earnings ratio of 39.10 and a beta of 0.65. The stock’s 50-day moving average is $17.39 and its two-hundred day moving average is $18.63.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.15 EPS for the quarter. Terumo had a return on equity of 8.26% and a net margin of 11.14%. The company had revenue of $1.66 billion for the quarter. As a group, analysts predict that Terumo will post 0.61 EPS for the current fiscal year.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.